Supernus Pharmaceuticals Inc (SUPN) — Working Capital to Net Assets Ratio
Supernus Pharmaceuticals Inc (SUPN) has a Working Capital to Net Assets ratio of 36.5% as of June 2026. Working capital of $376.12 Million (current assets of $723.50 Million minus current liabilities of $347.38 Million) is measured against net assets of $1.03 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Supernus Pharmaceuticals Inc to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Supernus Pharmaceuticals Inc Working Capital to Net Assets (2008–2025)
This chart shows how Supernus Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 36.5%, reflecting working capital of $376.12 Million against net assets of $1.03 Billion USD. For the complete balance sheet picture, see how large is Supernus Pharmaceuticals Inc's balance sheet.
Annual Working Capital to Net Assets for Supernus Pharmaceuticals Inc (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Supernus Pharmaceuticals Inc from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check SUPN asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 28.8% | $306.01 Million | $1.06 Billion | $644.18 Million | $338.17 Million | ▼ -9.2 pp |
| 2024 | 38.0% | $393.67 Million | $1.04 Billion | $686.07 Million | $292.40 Million | ▲ +16.0 pp |
| 2023 | 22.0% | $202.92 Million | $921.52 Million | $493.11 Million | $290.20 Million | ▲ +16.8 pp |
| 2022 | 5.2% | $46.19 Million | $886.20 Million | $734.15 Million | $687.96 Million | ▼ -29.9 pp |
| 2021 | 35.1% | $286.21 Million | $815.85 Million | $601.59 Million | $315.38 Million | ▼ -16.6 pp |
| 2020 | 51.7% | $385.31 Million | $744.86 Million | $630.42 Million | $245.11 Million | ▼ -0.7 pp |
| 2019 | 52.4% | $312.06 Million | $595.43 Million | $472.64 Million | $160.59 Million | ▼ -20.9 pp |
| 2018 | 73.3% | $332.13 Million | $453.02 Million | $493.49 Million | $161.35 Million | ▲ +33.9 pp |
| 2017 | 39.4% | $105.45 Million | $267.48 Million | $228.45 Million | $123.00 Million | ▲ +2.6 pp |
| 2016 | 36.9% | $70.66 Million | $191.75 Million | $151.40 Million | $80.74 Million | ▼ -5.1 pp |
| 2015 | 42.0% | $49.88 Million | $118.88 Million | $105.98 Million | $56.10 Million | ▼ -72.1 pp |
| 2014 | 114.1% | $81.40 Million | $71.35 Million | $108.89 Million | $27.49 Million | ▼ -97.4 pp |
| 2013 | 211.5% | $70.76 Million | $33.46 Million | $97.16 Million | $26.40 Million | ▲ +92.0 pp |
| 2012 | 119.4% | $68.76 Million | $57.57 Million | $91.74 Million | $22.98 Million | ▼ -204.9 pp |
| 2011 | 324.4% | $30.63 Million | $9.44 Million | $49.40 Million | $18.77 Million | ▲ +379.9 pp |
| 2010 | -55.5% | $24.61 Million | $-44.32 Million | $39.81 Million | $15.21 Million | ▲ +965.4 pp |
| 2009 | -1020.9% | $62.85 Million | $-6.16 Million | $72.88 Million | $10.03 Million | ▼ -114.1 pp |
| 2008 | -906.8% | $61.18 Million | $-6.75 Million | $69.46 Million | $8.27 Million | — |